ACURA PHARMACEUTICALS, INC. Retained Earnings
ACURA PHARMACEUTICALS, INC. had Retained Earnings of -$390.08 million as of 2021-12-31, per its 10-K filed 2023-06-30.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-06-30
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$390.08M.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$390.11M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$389.85M.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$389.46M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-12-31 | -$390.08M 10-K · filed 2023-06-30 |
| 2021-09-30 | -$390.11M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$389.85M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$389.46M 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$389.20M 10-K · filed 2023-06-30 |
| 2020-09-30 | -$388.96M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$388.28M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$388.59M 10-Q · filed 2020-06-29 |
| 2019-12-31 | -$388.00M 10-K · filed 2021-03-31 |
| 2019-09-30 | -$388.15M 10-Q · filed 2020-02-28 |
| 2019-06-30 | -$388.35M 10-Q · filed 2020-02-10 |
| 2019-03-31 | -$385.01M 10-Q · filed 2019-10-01 |
| 2018-12-31 | -$384.22M 10-K · filed 2020-03-31 |
| 2018-09-30 | -$384.23M 10-Q · filed 2018-11-27 |
| 2018-06-30 | -$383.13M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$381.87M 10-Q · filed 2018-06-29 |
| 2017-12-31 | -$380.38M 10-K · filed 2019-09-16 |
| 2017-09-30 | -$378.64M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$376.44M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$374.29M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$374.70M 10-K · filed 2018-06-07 |
| 2016-09-30 | -$376.23M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$373.98M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$370.69M 10-Q · filed 2016-05-02 |
| 2015-12-31 | -$367.31M 10-K · filed 2017-03-31 |
| 2015-09-30 | -$366.39M 10-Q · filed 2015-11-04 |
| 2015-06-30 | -$363.75M 10-Q · filed 2015-08-03 |
| 2015-03-31 | -$361.08M 10-Q · filed 2015-05-04 |
| 2014-12-31 | -$362.32M 10-K · filed 2016-02-29 |
| 2014-09-30 | -$359.63M 10-Q · filed 2014-11-03 |
| 2014-06-30 | -$356.72M 10-Q · filed 2014-08-04 |
| 2014-03-31 | -$353.20M 10-Q · filed 2014-05-05 |
| 2013-12-31 | -$349.11M 10-K · filed 2015-03-02 |
| 2013-09-30 | -$345.69M 10-Q · filed 2013-11-04 |
| 2013-06-30 | -$342.50M 10-Q · filed 2013-08-01 |
| 2013-03-31 | -$339.43M 10-Q · filed 2013-05-02 |
| 2012-12-31 | -$335.21M 10-K · filed 2014-03-03 |
| 2012-09-30 | -$332.19M 10-Q · filed 2012-11-06 |
| 2012-06-30 | -$330.06M 10-Q/A · filed 2012-08-09 |
| 2012-03-31 | -$327.88M 10-Q · filed 2012-05-01 |
| 2011-12-31 | -$325.54M 10-K · filed 2013-03-04 |
| 2011-09-30 | -$323.90M 10-Q · filed 2011-10-31 |
| 2011-06-30 | -$321.76M 10-Q · filed 2011-07-28 |
| 2010-12-31 | -$335.93M 10-K · filed 2012-03-05 |